Considerations for simultaneous testing of COVID-19 and tuberculosis in high-burden countries
Lancet Glob Health
.
2022 Apr;10(4):e465-e466.
doi: 10.1016/S2214-109X(22)00002-X.
Epub 2022 Feb 2.
Authors
Morten Ruhwald
1
,
Emma Hannay
2
,
Sanjay Sarin
2
,
Kekeletso Kao
2
,
Rajashree Sen
3
,
Sarabjit Chadha
3
Affiliations
1
FIND, Campus Biotech, Geneva 1202, Switzerland. Electronic address: morten.ruhwald@finddx.org.
2
FIND, Campus Biotech, Geneva 1202, Switzerland.
3
FIND, New Delhi, India.
PMID:
35122718
PMCID:
PMC8809899
DOI:
10.1016/S2214-109X(22)00002-X
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
SARS-CoV-2
Tuberculosis* / diagnosis
Tuberculosis* / epidemiology